Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.
Jack S. Cohen(McGill University), Robbe C. Lyon(National Institutes of Health), C. Chen(National Institutes of Health), Paula Faustino(National Institutes of Health), Gerald Batist(National Institutes of Health), Mark Shoemaker(National Institutes of Health), E. Rubalcaba(National Institutes of Health), K H Cowan(National Institutes of Health)
PubMed
August 1, 1986
Cited by 100
Abstract
31P magnetic resonance spectra of perfused human breast cancer cells with the phenotype of pleiotropic drug resistance exhibit striking differences in the levels of phosphate metabolites from the wild-type, drug-sensitive parent cell line. Resistant cells demonstrated elevated levels of phosphocreatine and depressed levels of phosphomonoesters, phosphodiesters, and diphosphodiesters. These differences may reflect significant alterations in the control of bioenergetic metabolism between drug-resistant and -sensitive cells.
Related Papers
31P nuclear magnetic resonance studies of Ehrlich ascites tumor cells.
Gil Navon, Satoshi Ogawa, R. G. Shulman et al.|Proceedings of the National Academy of Sciences|1977|187
Analysis of Intact Tissue with <sup>31</sup>P NMR
C. Tyler Burt, Sheila M. Cohen, Michael Bárány|Annual Review of Biophysics and Bioengineering|1979|131